Wayland Group Corp. MRRCF

MRRCF Company Overview

Wayland Group Corp. was a Canadian cannabis company that operated in the medical cannabis industry, with activities spanning cultivation, processing, product development, and international distribution. The company was formerly known as Maricann Group Inc. before rebranding to Wayland Group Corp. in 2018 as part of a broader international expansion strategy. Its business focused primarily on regulated cannabis markets, including medical cannabis production in Canada and European distribution opportunities, particularly in Germany.

The company’s principal revenue drivers were cannabis cultivation and related medical cannabis products, supported by licensed production assets and international market initiatives. Wayland positioned itself as an internationally oriented cannabis operator during the early expansion phase of the legal cannabis sector, emphasizing European medical cannabis demand and cross-border partnerships. Public filings and market disclosures indicate that the company pursued rapid scaling through acquisitions, facility development, and licensing initiatives; however, its operations later faced financial and restructuring challenges. Data regarding the company’s current operating status is inconclusive based on available public sources, though multiple filings and court-related disclosures indicate material insolvency and creditor-protection proceedings beginning in 2019.